Patent · US Expired

Preparation and drug composition of bis-benzyl-isoquinoline class alkaloids

US6617335B1 · kind B1 · utility

5Cited by
2References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 2, 2002
Grant dateSep 9, 2003
Priority date
Expiry dateMay 2, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D491/18
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This invention relates to the preparation of bis-isoquinoline derivatives of general formula (I) and salts thereof, which possesses multi-drug resistance (MDR) reversal activities. Drug compositions and formulations comprising bis-isoquinoline derivatives of general formula (I) and salts thereof are provided for use as sensitivity enhancers in cancer chemotherapy. Methods for inhibiting MDR by treatment with bis-isoquinoline derivatives are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.